Last reviewed · How we verify
NCT07142330: RAFAL
Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries
trial testing Atherectomy in Femoral Artery Occlusion in 120 participants. Not yet recruiting.
1 May 2026
Quick facts
| Lead sponsor | Ramsay Générale de Santé |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 September 2025 |
| Primary completion | 1 May 2026 |
| Estimated completion | 1 September 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- Atherectomy
Conditions studied
- Femoral Artery Occlusion — all drugs for Femoral Artery Occlusion →
- Atheromatous Plaques — all drugs for Atheromatous Plaques →
Sponsor
Ramsay Générale de Santé — full company profile →
Who can join
18 and older, any sex, with Femoral Artery Occlusion or Atheromatous Plaques. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Thromboendarterectomy is the standard technique for the treatment of symptomatic occlusive lesions of the common femoral artery. It consists of surgically controlling the artery and interrupting circulation, opening the vessel and removing the atherosclerotic plaque. However, this technique is associated with healing difficulties, postoperative infections, and debilitating incisional pain. The rise of endovascular therapies, particularly at the coronary level, has led to the emergence of new deocclusion techniques, including rotational atherectomy. This technique relies on the use of an intravascular catheter that reams out the atherosclerotic plaque while re-aspirating the resulting debris. A few studies have examined the use of rotational atherectomy for occlusive lesions of the common femoral arteries, but have not evaluated its results compared to the standard treatment. The aim of this multicenter cohort is to describe the efficacy and safety of rotational atherectomy and the standard treatment, thromboendarterectomy, in symptomatic occlusive lesions affecting the common femoral artery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07142330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Atherectomy
Trials testing the same drug.
- NCT04793581 — Assessment of the Utility of the Pantheris Small Vessel (SV) System · NA · recruiting
- NCT04241224 — A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages · NA · completed
- NCT04092972 — Safety and Efficacy of Atherectomy on VasculaR Functions · NA · unknown
- NCT02475200 — Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems · completed
Other Ramsay Générale de Santé trials
Trials by the same sponsor.
- NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
- NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
- NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
- NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting
- NCT06877936 — Determination of Scapulothoracic and Glenohumeral Angles by Imaging in Patients After Shoulder Arthroplasty (SCAP-imag) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07142330 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
- Last refreshed: 26 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07142330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing